View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
June 14, 2018updated 10 Dec 2018 4:47pm

The Pros and Cons of Just in Time Labelling

Guglielmo Migliori runs the rule on the advantages and disadvantages of Just-in-Time labelling

By Staff Writer

Over the past few months, I have conducted research with members of the pharma industry, discussing a wide range of topics. Chief among them was Just-in-Time (JIT) labelling. Many questions surround the worth of JIT – is it really something that simplifies the labelling process? Or is it just another overrated method? Given recent developments on global inspections, JIT labelling could be the answer you were looking for.

Free Whitepaper
img

6 Keys to Simplified Labeling Changes in Life Sciences

If you are responsible for managing the change process of labels and related components, or if you’re a stakeholder in the process, you likely have a good understanding of its complexities and challenges. From automated quality checks to organisational change management, leading life sciences label management experts Esko explores here six ways you can simplify label changes and help mitigate the risk of costly – or fatal - labelling errors.
by Esko
Enter your details here to receive your free Whitepaper.

After having prepared a vast network of suppliers from across the globe, naturally each country possesses different regulatory needs, therefore sponsors must account for those requirements in their clinical label. This could be incredibly beneficial – if the IMP is to enter 10 different countries at the same time, and the booklet labels aren’t available, this could mean an extremely long label containing an excessive number of differing languages.

This has created a huge problem, as the ultimate desire is to have a label that contains the language specific to a certain country. How can companies therefore maximize the use of their product then? How can sponsors dispense of it and move it more quickly? By delaying product configuration, taking action by country or by study, your clinical labelling process should be completed as late as possible, to achieve a greater level of flexibility. This could become a common manufacturing process.

However, bear in mind, with various pieces at play on the board, much can go wrong if left unaccounted for. For that reason, finding the key to success could prove complicated and in some cases, the extra workload could delay the whole process. It could be thought that the JIT method is not exactly the panacea, but it may be a solution in extreme cases.

For instance, if working on a lean packaging project for a trial, can JIT help in releasing drugs more efficiently in a matter of days? Or what if there are 200 packages sent to many different corners around the world, and each country needs its corresponding paperwork to be filled. It could become very risky and time consuming as someone in the relevant department would have to explain all of the needed requirements to someone else, who may have a totally different professional culture. This could mean that then, after releasing the drug, many oversight steps should be taken. In recent times, the idea of using recognized symbols in lieu of languages has been touted as a solution. This could save significant time, as with symbols arguably little could left open to interpretation. But whether they are ultimately the answer, only time will tell.

Related Companies

Free Whitepaper
img

6 Keys to Simplified Labeling Changes in Life Sciences

If you are responsible for managing the change process of labels and related components, or if you’re a stakeholder in the process, you likely have a good understanding of its complexities and challenges. From automated quality checks to organisational change management, leading life sciences label management experts Esko explores here six ways you can simplify label changes and help mitigate the risk of costly – or fatal - labelling errors.
by Esko
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena